Literature DB >> 14585236

Fulminant Hepatic Failure.

Albert J. Chang1, Vivek Dixit, Sammy Saab.   

Abstract

Fulminant hepatic failure is a rapidly progressive and often fatal syndrome, and the only definitive treatment is liver transplantation. However, given the scarcity of available grafts, the mainstay of therapy remains supportive care until there is spontaneous recovery or until a suitable donor liver becomes available. After initial assessment and stabilization, patients should be transferred to the nearest liver transplant center as soon as possible, as they can deteriorate rapidly. All patients with fulminant hepatic failure must be monitored closely and treated for hepatic encephalopathy, coagulopathy, gastrointestinal bleeding, renal failure, cerebral edema, and metabolic derangement.

Entities:  

Year:  2003        PMID: 14585236     DOI: 10.1007/s11938-003-0049-y

Source DB:  PubMed          Journal:  Curr Treat Options Gastroenterol        ISSN: 1092-8472


  21 in total

Review 1.  Nutritional therapies in liver disease.

Authors:  S J Muñoz
Journal:  Semin Liver Dis       Date:  1991-11       Impact factor: 6.115

Review 2.  Mechanism of action and value of N-acetylcysteine in the treatment of early and late acetaminophen poisoning: a critical review.

Authors:  A L Jones
Journal:  J Toxicol Clin Toxicol       Date:  1998

Review 3.  Acute liver failure.

Authors:  W M Lee
Journal:  N Engl J Med       Date:  1993-12-16       Impact factor: 91.245

4.  Acute liver failure.

Authors:  R J Fontana; L G Quallich
Journal:  Curr Opin Gastroenterol       Date:  2001-05       Impact factor: 3.287

Review 5.  Acute hepatic failure: a Western perspective.

Authors:  G Ostapowicz; W M Lee
Journal:  J Gastroenterol Hepatol       Date:  2000-05       Impact factor: 4.029

Review 6.  Acute liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure.

Authors:  S M Riordan; R Williams
Journal:  J Hepatol       Date:  2000       Impact factor: 25.083

7.  Liver transplantation for fulminant hepatic failure: experience with more than 200 patients over a 17-year period.

Authors:  Douglas G Farmer; Dean M Anselmo; R Mark Ghobrial; Hasan Yersiz; Suzanne V McDiarmid; Carlos Cao; Michael Weaver; Jesus Figueroa; Khurram Khan; Jorge Vargas; Sammy Saab; Steven Han; Francisco Durazo; Leonard Goldstein; Curtis Holt; Ronald W Busuttil
Journal:  Ann Surg       Date:  2003-05       Impact factor: 12.969

8.  Multivariate analysis of prognostic factors in fulminant hepatitis B.

Authors:  J Bernuau; A Goudeau; T Poynard; F Dubois; G Lesage; B Yvonnet; C Degott; A Bezeaud; B Rueff; J P Benhamou
Journal:  Hepatology       Date:  1986 Jul-Aug       Impact factor: 17.425

9.  Early indicators of prognosis in fulminant hepatic failure.

Authors:  J G O'Grady; G J Alexander; K M Hayllar; R Williams
Journal:  Gastroenterology       Date:  1989-08       Impact factor: 22.682

10.  Prospective controlled trial of selective parenteral and enteral antimicrobial regimen in fulminant liver failure.

Authors:  N Rolando; A Gimson; J Wade; J Philpott-Howard; M Casewell; R Williams
Journal:  Hepatology       Date:  1993-02       Impact factor: 17.425

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.